MedPath

hypotensive effect of amla ( Emblica officinalis)

Phase 2
Recruiting
Conditions
hypertension.
Essential (primary) hypertension
Registration Number
IRCT20090527001957N7
Lead Sponsor
Research Institute for Islamic and Complementary Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

SBP>=140 mmHg
SBP>=150 mmHg in 60 year old or older patients
DBP>=90 mmHg

Exclusion Criteria

SBP>180 mmHg
DBP>110 mmHg
secondary hypertension
hypertensive encephalopathy
Hypertensive retinopathy grade 3,4
Acute cerebrovascular accident
Acute coronary syndrome
decompensated congestive heart failure
creatinin > 1.5 times more than normal limit
ALT> 3 times more than normal limit
diabetic complications
coagulopathy
use of anticoagulants and anti platelet drugs
use of NSAIDS
platelet<100000

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Systolic blood pressure. Timepoint: before the intervention, at the end of the first and second month after intervention. Method of measurement: mercury barometer.;Diastolic blood pressure. Timepoint: before the intervention, at the end of the first and second month after intervention. Method of measurement: mercury barometer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath